Association between spine disc degeneration and type II collagen degradation in postmenopausal women: The OFELY study

Arthritis and Rheumatism

Volumn 50, Issue 10, 2004, Pages 3137-3144

  Garnero, Patrick ^a,c   Sornay Rendu, Elisabeth ^a   Arlot, Monique ^a   Christiansen, Claus ^b   Delmas, Pierre D ^a  

^a INSERM   (France)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 2;

ADULT; AGED; ARTICLE; BONE METABOLISM; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HAND; HIP OSTEOARTHRITIS; HUMAN; INTERVERTEBRAL DISK DEGENERATION; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPHYTE; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SPINE RADIOGRAPHY; THORACIC SPINE; URINE LEVEL;

ADULT; AGED; COLLAGEN TYPE II; FEMALE; HAND; HUMANS; INTERVERTEBRAL DISK; KNEE JOINT; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOARTHRITIS; PEPTIDE FRAGMENTS; POSTMENOPAUSE; SPINAL DISEASES; SPINAL OSTEOPHYTOSIS; SPINAL STENOSIS; THORACIC VERTEBRAE;

EID: 5644224430     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20493     Document Type: Article

References (38)

1. Resnick D, Niwayama G. Degenerative disease of the spine. In: Resnick D, Niwayama G, editors. Diagnosis of bone and joint disorders. 2nd ed. Philadelphia: Saunders; 1998. p. 1480-561.
2. Dennison E, Cooper C. Osteoarthritis: epidemiology and classification. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 3rd ed. Edinburg: Mosby; 2003. p. 1781-92.
3. Chung SA, Khan SN, Diwan AD. The molecular basis of intervertebral disc degeneration. Orthop Clin North Am 2003;34:209-19.
4. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritis articular cartilage. J Clin Invest 1997;99:1534-45.
5. Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander A, Poole RA, et al. The human intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix during growth, maturation, ageing and degeneration. J Clin Invest 1996;98:996-1003.
6. Garnero P, Rousseau J-C, Delmas PD. Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 2000;43:953-61.
7. Garnero P, Delmas PD. Biomarkers in osteoarthritis. Curr Opin Rheumatol 2003;15:641-6.
8. Poole AR. Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis? Arthritis Rheum 2002;46:2549-52.
9. Poole AR. Defining and validating the clinical role of molecular markers in osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, editors. Osteoarthritis. 2nd ed. Oxford: Oxford University Press; 2003.
10. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage of type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-32.
11. Downs JT, Lane CL, Nestor NB, McLellan TJ, Kelly MA, Karam GA, et al. Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA. J Immunol Methods 2001;247:25-34.
12. Lohmander LS, Atley LM, Pietka TA, Eyre DR. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 2003;48:3130-9.
13. Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001;29:209-15.
14. Woodworth TG, Otterness IG, Johnson K, Pickering E, Saltarelli MJ. Urinary type II collagen neoepitope (uTIINE) in osteoarthritis (OA) patients is associated with disease severity [abstract]. Arthritis Rheum 1999;42 Suppl 9:S258.
15. Saltarelli MJ, Johnson KS, Pickering E, Otterness IG, Vasquez-Abad MD, Woodworth TG. Measurement of urinary type II collagen neoepitope (uTIINE) levels in rheumatoid arthritis (RA) patients to assess joint status [abstract]. Arthritis Rheum 1999;42 Suppl 9:S249.
16. Kraus VB, Stabler T, Le ET, Saltarelli M, Allen NB. Urinary type II collagen neoepitope as an outcome measure for relapsing polychondritis. Arthritis Rheum 2003;48:2942-8.
17. Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, et al. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum 2003;48:3085-95.
18. Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 2002;46:2613-24.
19. Garnero P, Conrozier T, Christgau S, Mathieu P, Delmas PD, Vignon E. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis 2003;62:939-43.
20. Garnero P, Landewé R, Boers M, Verhoeven A, van der Linden S, Christgau S, et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 2002;46:2847-56.
21. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;11:337-49.
22. Garnero P, Mulleman D, Munoz F, Sornay-Rendu E, Delmas PD. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study. J Bone Miner Res 2003;18:1789-94.
23. Mouritzen U, Christgau S, Lehmann H-J, Tanko LB, Christiansen C. Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy and body mass index. Ann Rheum Dis 2003;62:332-6.
24. Lane NE, Nevitt MC, Genant HK, Hochberg MC. Reliability of new indices of radiographic osteoarthritis of the hand and hip and lumbar spine degeneration. J Rheumatol 1993;20:1911-8.
25. Peterfy C, Li J, Zaim S, Duryea J, Lynch J, Miaux Y, et al. Comparison of fixed-flexion positioning with fluoroscopic semiflexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility. Skeletal Radiol. 2003;32:128-32.
26. Altman RD, Hochberg M, Murphy WA Jr, Wolfe F, Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage 1995;3 Suppl A:3-70.
27. Hart D, Spector T, Egger P, Coggon D, Cooper C. Defining osteoarthritis of the hand for epidemiological studies: the Chingford study. Ann Rheum Dis 1994;53:220-3.
28. Peel NF, Barrington NA, Blumsohn A, Colwell A, Hannon R, Eastell R. Bone mineral density and bone turnover in spinal osteoarthritis. Ann Rhem Dis 1995;54:867-71.
29. Jones G, Nguyen T, Sambrook PN, Kelly PJ, Eisman JA. A longitudinal study of the effect of spinal degenerative disease on bone density in the elderly. J Rheumatol 1995;22:932-6.
30. Liu G, Peacock M, Eilam O, Dorulla G, Braunstein E, Johnston CC. Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int 1997;7:564-9.
31. O'Neill TW, McCloskey EV, Kanis JA, Bhalla AK, Reeve J, Reid DM, et al. The distribution, determinants, and clinical correlates of vertebral osteophytosis: a population based survey. J Rheumatol 1999;26:842-8.
32. Hassett G, Hart DJ, Manek NJ, Doyle DV, Spector TD. Risk factors for progression of lumbar spine disc degeneration: the Chingford study. Arthritis Rheum 2003;11:3112-7.
33. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001;60:619-26.
34. El Miedany YM, Mehanna AN, El Baddini MA. Altered bone mineral metabolism in patients with osteoarthritis. Joint Bone Spine 2000;67:521-7.
35. Adams P, Eyre DR, Muir H. Biochemical aspects of development and ageing of human intervertebral discs. Rheumatol Rehabil 1977;16:22-9.
36. Bijkerk C, Houwing-Duistermaat JJ, Valkenburg HA, Meulenbelt I, Hofman A, Breedveld FC, et al. Heritabilities of radiological osteoarthritis in peripheral joints and of disc degeneration of the spine. Arthritis Rheum 1999;42:1729-35.
37. Cicuttini FM, Baker J, Hart DJ, Spector TD. Relation between Heberden's nodes and distal interphalangeal joint osteophytes and their role as markers of generalized disease. Ann Rheum Dis 1998;57:246-8.
38. Stern AG, Moxley G, Sudha Rao TP, Disler D, McDowell C, Park M, et al. Utility of digital photograph of the hand for assessing the presence of hand osteoarthritis. Osteoarthritis Cartilage 2004;12:360-5.